Performs testing and analysis on the identification and reduction of cardiovascular inflammation. CHL's prognostic tests better predict risk beyond standard risk factors and its R&D department is tasked with the discovery and commercial development of next-generation cardiovascular biomarkers.
Inc. 5000 Rankings
No. 543 (2014)
WebsiteData as of Publication on